Table 1.

Characteristics and Results of the Reviewed Articles (n = 13)

iSR’obot™ MonaLisa (Biobot Surgical, Singapore)
Author, Year	Type of Study	N	Design of the Study	Cancer Detection Rate	Complication Rate
Trotsenko et al 202314	Prospective	157	Primary results	–	–
Walter et al 202224	Prospective	228	Primary results	–	14%
Wetterauer et al 202133	Prospective	118	Systematic Versus Targeted Biopsy	1 core: 39.1% 2 cores: 52.2% 3 cores: 67.4%	–
Yang et al 202025	Prospective	30	Primary results	63.3% (all) 50.0% (csPca)	6.7% 1 urosepsis 1 Aur
Lee et al 202017	Retrospective	433	Systematic Versus Targeted Biopsy	%57 %46 (csPca)	–
Patel et al 202018	Retrospective, multicentre	92	COG-TB Versus Targeted Biopsy	60.4% (all) 39.6% (csPca)	Aur 1.9% Haematuria 7.5% Perineal bruising 8%
Miah et al 201912	Prospective	86	Primary results	51.2% (all)	1 urosepsis
Mischinger et al 201834	Prospective	232	Primary results	61% (all) 45.3% (csPca)	3% 1 rectal injury/peritonitis 6 Aur 3 Perineal bruising
Kaufmann et al 201820	Prospective	73	Robotic TP, In‐bore and COG-TB	52.4% (all) 35.6% (csPca)	–
Chen et al 201716	Prospective	19	Combination MRI-targeted and transperineal template biopsy	73.7% (all) 15.8% (csPca)	–
Kaufmann et al 201728	Prospective	55	Primary results	61.8 (all) 52.7% (csPca)	Aur 5.4% Major bleeding 1.8% Minor bleeding 9.1%
Kroenig et al 201627	Retrospective	52	Primary results	59.6% (all) 51.9% (csPca)	2 patients (temporary bleeding and a rectum perforation)
Artemis™ (Eigen, USA)
Author, Year	Type of Study	N	Design of the Study	Cancer Detection Rate	Complication Rate
Claros et al 202019	Prospective	269	Cognitive microUSG Versus Robotic Tp	23% (csPca)	–

AUR, acute urinary retention; COG-TB, cognitive targeted biopsy; csPca, clinically significant prostate cancer; MRI, magnetic resonance imaging; TP, transperineal; USG, ultrasonography.